Cullinan Therapeutics Investor Relations Material
Latest events
Status Update
Cullinan Therapeutics
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Cullinan Therapeutics Inc
Access all reports
Cullinan Oncology Inc, is a clinical-stage biopharmaceutical company focused on developing innovative cancer therapies. Leveraging a modality-agnostic approach, Cullinan Oncology is dedicated to discovering and developing medicines for high-impact oncology targets. The company's strategy involves rigorous and rapid advancement of highly differentiated molecules, resulting in a robust and diversified pipeline of oncology and immuno-oncology therapies. The company is headquartered in Cambridge, Massachusetts, and its shares are listed on the NASDAQ.
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
CGEM
Country
🇺🇸 United States